Skip to main content
Top
Published in: Pituitary 3/2015

01-06-2015

Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly

Authors: S. H. P. P. Roerink, M. A. E. M. Wagenmakers, J. F. Wessels, R. B. T. M. Sterenborg, J. W. Smit, A. R. M. M. Hermus, R. T. Netea-Maier

Published in: Pituitary | Issue 3/2015

Login to get access

Abstract

Context

Acromegaly is associated with impaired quality of life (QoL) and causes anatomical disproportions, which may contribute to the decreased QoL after successful treatment. The Derriford appearance scale 59 (DAS59) is a questionnaire measuring psychological distress and disruptions to everyday life associated with self-consciousness of appearance.

Objective

Investigate the psychological distress and dysfunction related to self-consciousness about appearance and its effect on QoL in patients in long-term remission of acromegaly.

Patients, design and methods

Patients (>18 years old) treated for acromegaly at the Department of Endocrinology of the Radboud University Medical Center Nijmegen were invited to participate. A gender-, age- and body mass index matched control group was provided by the patients themselves. Participants were asked to complete the modified DAS59-, research and development 36- (RAND-36), acromegaly quality of life questionnaire (AcroQoL) and a sociodemographic questionnaire. Differences between patient- and control groups and correlations between questionnaire scores and clinical characteristics collected from medical records were analyzed.

Main outcome measures

Questionnaire scores.

Results

Of the 120 respondents, 73 agreed to participate [all cured or under biochemical control, median remission time 10.5 years (range 2.3–43.6 years)]. Of these, 34 (46.6 %) reported self-consciousness about their appearance. Twenty-nine of these patients (85.3 %) pointed out their face to be a prominent source of self-consciousness. Fifty-seven matched control subjects were included as well. Significant correlations were found between the scores of the DAS59 and the AcroQoL, RAND-36 and VAS in patients.

Conclusions

Even after long-term remission of acromegaly, a large number of patients are self-conscious about their appearance, leading to psychological distress and disruptions to everyday life and decreased QoL. Facial features were the most important source of self-consciousness. This stresses the importance of addressing self-consciousness of appearance and the need for additional support in this regard during follow-up in these patients.
Literature
1.
go back to reference Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J, Vance ML, Ho K, Giustina A, Acromegaly Consensus Group (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94(5):1509–1517. doi:10.1210/jc.2008-2421 CrossRefPubMed Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J, Vance ML, Ho K, Giustina A, Acromegaly Consensus Group (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94(5):1509–1517. doi:10.​1210/​jc.​2008-2421 CrossRefPubMed
2.
go back to reference Wagenmakers MA, Roerink SH, Maal TJ, Pelleboer RH, Smit JW, Hermus AR, Berge SJ, Netea-Maier RT, Xi T (2014) Three-dimensional facial analysis in acromegaly: a novel tool to quantify craniofacial characteristics after long-term remission. Pituitary. doi:10.1007/s11102-014-0565-x PubMed Wagenmakers MA, Roerink SH, Maal TJ, Pelleboer RH, Smit JW, Hermus AR, Berge SJ, Netea-Maier RT, Xi T (2014) Three-dimensional facial analysis in acromegaly: a novel tool to quantify craniofacial characteristics after long-term remission. Pituitary. doi:10.​1007/​s11102-014-0565-x PubMed
4.
go back to reference Trepp R, Everts R, Stettler C, Fischli S, Allemann S, Webb SM, Christ ER (2005) Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the acromegaly quality of life questionnaire (AcroQoL). Clin Endocrinol 63(1):103–110. doi:10.1111/j.1365-2265.2005.02307.x CrossRef Trepp R, Everts R, Stettler C, Fischli S, Allemann S, Webb SM, Christ ER (2005) Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the acromegaly quality of life questionnaire (AcroQoL). Clin Endocrinol 63(1):103–110. doi:10.​1111/​j.​1365-2265.​2005.​02307.​x CrossRef
6.
go back to reference Matta MP, Couture E, Cazals L, Vezzosi D, Bennet A, Caron P (2008) Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance. Eur J Endocrinol 158(3):305–310. doi:10.1530/EJE-07-0697 CrossRefPubMed Matta MP, Couture E, Cazals L, Vezzosi D, Bennet A, Caron P (2008) Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance. Eur J Endocrinol 158(3):305–310. doi:10.​1530/​EJE-07-0697 CrossRefPubMed
8.
go back to reference Webb SM, Badia X, Surinach NL, Spanish AcroQol Study Group (2006) Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol 155(2):269–277. doi:10.1530/eje.1.02214 CrossRefPubMed Webb SM, Badia X, Surinach NL, Spanish AcroQol Study Group (2006) Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol 155(2):269–277. doi:10.​1530/​eje.​1.​02214 CrossRefPubMed
9.
go back to reference Harris DL, Carr AT (2001) The Derriford appearance scale (DAS59): a new psychometric scale for the evaluation of patients with disfigurements and aesthetic problems of appearance. Br J Plast Surg 54(3):216–222. doi:10.1054/bjps.2001.3559 CrossRefPubMed Harris DL, Carr AT (2001) The Derriford appearance scale (DAS59): a new psychometric scale for the evaluation of patients with disfigurements and aesthetic problems of appearance. Br J Plast Surg 54(3):216–222. doi:10.​1054/​bjps.​2001.​3559 CrossRefPubMed
10.
go back to reference Klassen A, Jenkinson C, Fitzpatrick R, Goodacre T (1998) Measuring quality of life in cosmetic surgery patients with a condition-specific instrument: the Derriford scale. Br J Plast Surg 51(5):380–384CrossRefPubMed Klassen A, Jenkinson C, Fitzpatrick R, Goodacre T (1998) Measuring quality of life in cosmetic surgery patients with a condition-specific instrument: the Derriford scale. Br J Plast Surg 51(5):380–384CrossRefPubMed
12.
go back to reference Streeter VM, Milhausen RR, Buchholz AC (2012) Body image, body mass index, and body composition in young adults. Can J Diet Pract Res 73(2):78–83CrossRefPubMed Streeter VM, Milhausen RR, Buchholz AC (2012) Body image, body mass index, and body composition in young adults. Can J Diet Pract Res 73(2):78–83CrossRefPubMed
13.
go back to reference Harris DL, Carr A, Moss T (1996) Derriford appearance scale 59 (DAS59) manual. Musketeer Press, Bradford on Avon Harris DL, Carr A, Moss T (1996) Derriford appearance scale 59 (DAS59) manual. Musketeer Press, Bradford on Avon
15.
go back to reference Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46(12):1417–1432CrossRefPubMed Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46(12):1417–1432CrossRefPubMed
17.
go back to reference Webb SM, Prieto L, Badia X, Albareda M, Catala M, Gaztambide S, Lucas T, Paramo C, Pico A, Lucas A, Halperin I, Obiols G, Astorga R (2002) Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol 57(2):251–258CrossRef Webb SM, Prieto L, Badia X, Albareda M, Catala M, Gaztambide S, Lucas T, Paramo C, Pico A, Lucas A, Halperin I, Obiols G, Astorga R (2002) Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol 57(2):251–258CrossRef
18.
go back to reference Pieters GF, Smals AG, Kloppenborg PW (1980) Defective suppression of growth hormone after oral glucose loading in adolescence. J Clin Endocrinol Metab 51(2):265–270CrossRefPubMed Pieters GF, Smals AG, Kloppenborg PW (1980) Defective suppression of growth hormone after oral glucose loading in adolescence. J Clin Endocrinol Metab 51(2):265–270CrossRefPubMed
19.
go back to reference Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML, Endocrine Society’s Clinical Guidelines Subcommittee, Stephens PA (2006) Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91(5):1621–1634. doi:10.1210/jc.2005-2227 CrossRefPubMed Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML, Endocrine Society’s Clinical Guidelines Subcommittee, Stephens PA (2006) Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91(5):1621–1634. doi:10.​1210/​jc.​2005-2227 CrossRefPubMed
21.
go back to reference Kauppinen-Makelin R, Sane T, Sintonen H, Markkanen H, Valimaki MJ, Loyttyniemi E, Niskanen L, Reunanen A, Stenman UH (2006) Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab 91(10):3891–3896. doi:10.1210/jc.2006-0676 CrossRefPubMed Kauppinen-Makelin R, Sane T, Sintonen H, Markkanen H, Valimaki MJ, Loyttyniemi E, Niskanen L, Reunanen A, Stenman UH (2006) Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab 91(10):3891–3896. doi:10.​1210/​jc.​2006-0676 CrossRefPubMed
22.
go back to reference Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F (2005) Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 90(5):2731–2739. doi:10.1210/jc.2004-2297 CrossRefPubMed Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F (2005) Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 90(5):2731–2739. doi:10.​1210/​jc.​2004-2297 CrossRefPubMed
23.
go back to reference Converse JM, Baker DC (1978) Surgical correction of the facial deformities of acromegaly. Ann Plast Surg 1(6):612–616CrossRefPubMed Converse JM, Baker DC (1978) Surgical correction of the facial deformities of acromegaly. Ann Plast Surg 1(6):612–616CrossRefPubMed
24.
go back to reference Ousterhout DK, Penoff JH (1981) Surgical treatment of facial deformity secondary to acromegaly. Ann Plast Surg 7(1):68–74CrossRefPubMed Ousterhout DK, Penoff JH (1981) Surgical treatment of facial deformity secondary to acromegaly. Ann Plast Surg 7(1):68–74CrossRefPubMed
25.
go back to reference Serra Payro JM, Vinals Vinals JM, Palacin Porte JA, Estrada Cuixart J, Lerma Gonce J, Alarcon Perez J (1994) Surgical management of the acromegalic face. J Craniofac Surg 5(5):336–338CrossRefPubMed Serra Payro JM, Vinals Vinals JM, Palacin Porte JA, Estrada Cuixart J, Lerma Gonce J, Alarcon Perez J (1994) Surgical management of the acromegalic face. J Craniofac Surg 5(5):336–338CrossRefPubMed
26.
go back to reference Chung KC, Buchman SR, Aly HM, Trotman CA (1996) Use of modern craniofacial techniques for comprehensive reconstruction of the acromegalic face. Ann Plast Surg 36(4):403–408 (discussion 408–409)CrossRefPubMed Chung KC, Buchman SR, Aly HM, Trotman CA (1996) Use of modern craniofacial techniques for comprehensive reconstruction of the acromegalic face. Ann Plast Surg 36(4):403–408 (discussion 408–409)CrossRefPubMed
27.
go back to reference Boudrez H, De Backer G (2001) Psychological status and the role of coping style after coronary artery bypass graft surgery. Results of a prospective study. Qual Life Res 10(1):37–47CrossRefPubMed Boudrez H, De Backer G (2001) Psychological status and the role of coping style after coronary artery bypass graft surgery. Results of a prospective study. Qual Life Res 10(1):37–47CrossRefPubMed
29.
go back to reference Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR (2011) Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 96(4):964–971. doi:10.1210/jc.2010-2490 CrossRefPubMed Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR (2011) Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 96(4):964–971. doi:10.​1210/​jc.​2010-2490 CrossRefPubMed
30.
go back to reference Thorndike EL (1920) A constant error on psychological rating. J Appl Psychol 4:25–29CrossRef Thorndike EL (1920) A constant error on psychological rating. J Appl Psychol 4:25–29CrossRef
31.
go back to reference Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM (2002) Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 57(5):577–585CrossRef Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM (2002) Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 57(5):577–585CrossRef
32.
go back to reference Hatipoglu E, Topsakal N, Atilgan OE, Alcalar N, Camliguney AF, Niyazoglu M, Cotuk HB, Kadioglu P (2014) Impact of exercise on quality of life and body-self perception of patients with acromegaly. Pituitary 17(1):38–43. doi:10.1007/s11102-013-0463-7 CrossRefPubMed Hatipoglu E, Topsakal N, Atilgan OE, Alcalar N, Camliguney AF, Niyazoglu M, Cotuk HB, Kadioglu P (2014) Impact of exercise on quality of life and body-self perception of patients with acromegaly. Pituitary 17(1):38–43. doi:10.​1007/​s11102-013-0463-7 CrossRefPubMed
Metadata
Title
Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly
Authors
S. H. P. P. Roerink
M. A. E. M. Wagenmakers
J. F. Wessels
R. B. T. M. Sterenborg
J. W. Smit
A. R. M. M. Hermus
R. T. Netea-Maier
Publication date
01-06-2015
Publisher
Springer US
Published in
Pituitary / Issue 3/2015
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-014-0583-8

Other articles of this Issue 3/2015

Pituitary 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.